White House Adviser Says Trump Won’t Create ‘FDA for AI’ - PYMNTS.com

The Trump administration has decided not to create a dedicated regulatory body for AI (similar to the FDA for drugs), signaling a lighter regulatory approach to the industry. This affects how AI development and deployment will be governed in the U.S.